CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Louisville, Kentucky, United States and 23 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Louisville, Kentucky, United States and 216 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Louisville, Kentucky, United States and 131 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Louisville, Kentucky, United States and 506 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Louisville, Kentucky, United States and 508 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Louisville, Kentucky, United States and 273 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Louisville, Kentucky, United States and 357 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Louisville, Kentucky, United States and 275 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib [AZD1775]) in second or third line setting in patients with Triple...
Phase 2
Louisville, Kentucky, United States and 140 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Louisville, Kentucky, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal